Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis

The introduction of biological agents targeting tumor necrosis factor-alpha (TNF-α) has brought about a paradigm shift in the treatment of rheumatoid arthritis (RA). Although these anti-TNF agents have excellent efficacy against RA, a substantial number of patients still show inadequate responses. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Koike, Ryuji, Harigai, Masayoshi, Atsumi, Tatsuya, Amano, Koichi, Kawai, Shinichi, Saito, Kazuyoshi, Saito, Tomoyuki, Yamamura, Masahiro, Matsubara, Tsukasa, Miyasaka, Nobuyuki
Formato: Texto
Lenguaje:English
Publicado: Springer Japan 2009
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720589/
https://www.ncbi.nlm.nih.gov/pubmed/19590933
http://dx.doi.org/10.1007/s10165-009-0197-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720589/
https://www.ncbi.nlm.nih.gov/pubmed/19590933
http://dx.doi.org/10.1007/s10165-009-0197-6

Ejemplares similares